1281 related articles for article (PubMed ID: 14984368)
21. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
Xia T; Zeng G; Gao L; Yu RK
Gene; 2005 May; 351():109-18. PubMed ID: 15890474
[TBL] [Abstract][Full Text] [Related]
22. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
23. Cyclic adenosine monophosphate (cAMP) stimulation of the kit ligand promoter in sertoli cells requires an Sp1-binding region, a canonical TATA box, and a cAMP-induced factor binding to an immediately downstream GC-rich element.
Grimaldi P; Capolunghi F; Geremia R; Rossi P
Biol Reprod; 2003 Dec; 69(6):1979-88. PubMed ID: 12904318
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation in endoderm development: characterization of an enhancer controlling Hnf3g expression by transgenesis and targeted mutagenesis.
Hiemisch H; Schütz G; Kaestner KH
EMBO J; 1997 Jul; 16(13):3995-4006. PubMed ID: 9233809
[TBL] [Abstract][Full Text] [Related]
25. Promoter region of the human gene coding for beta-chain of C4b binding protein. Hepatocyte nuclear factor-3 and nuclear factor-I/CTF transcription factors are required for efficient expression of C4BPB in HepG2 cells.
Arenzana N; Rodríguez de Córdoba S
J Immunol; 1996 Jan; 156(1):168-75. PubMed ID: 8598458
[TBL] [Abstract][Full Text] [Related]
26. Cloning and characterization of lipopolysaccharide-induced tumor necrosis factor alpha factor promoter.
Shiomi N; Myokai F; Naruishi K; Oyaizu K; Senoo K; Yamaguchi T; Amar S; Takashiba S
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):360-8. PubMed ID: 16872372
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of down-regulation of CYP2E1 expression by inflammatory cytokines in rat hepatoma cells.
Hakkola J; Hu Y; Ingelman-Sundberg M
J Pharmacol Exp Ther; 2003 Mar; 304(3):1048-54. PubMed ID: 12604681
[TBL] [Abstract][Full Text] [Related]
28. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the human C6 promoter: requirement of the CCAAT enhancer binding protein binding site for C6 gene promoter activity.
González S; López-Larrea C
J Immunol; 1996 Sep; 157(6):2282-90. PubMed ID: 8805625
[TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of a genomic region upstream from the ovine Na+/d-glucose cotransporter (SGLT1) cDNA.
Wood IS; Allison GG; Shirazi-Beechey SP
Biochem Biophys Res Commun; 1999 Apr; 257(2):533-7. PubMed ID: 10198246
[TBL] [Abstract][Full Text] [Related]
31. Identification and analysis of the human neural polypyrimidine tract binding protein (nPTB) gene promoter region.
Romanelli MG; Lorenzi P; Morandi C
Gene; 2005 Aug; 356():11-8. PubMed ID: 16002244
[TBL] [Abstract][Full Text] [Related]
32. GC-rich elements flanking the transcription start site govern strong activation on the SNURF gene.
Hirvonen SJ; Santti H; Jänne OA; Palvimo JJ
Biochem Biophys Res Commun; 2002 Mar; 291(4):897-902. PubMed ID: 11866449
[TBL] [Abstract][Full Text] [Related]
33. The pig CYP2E1 promoter is activated by COUP-TF1 and HNF-1 and is inhibited by androstenone.
Tambyrajah WS; Doran E; Wood JD; McGivan JD
Arch Biochem Biophys; 2004 Nov; 431(2):252-60. PubMed ID: 15488474
[TBL] [Abstract][Full Text] [Related]
34. The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinoma.
Tomassetti A; Mangiarotti F; Mazzi M; Sforzini S; Miotti S; Galmozzi E; Elwood PC; Canevari S
Cancer Res; 2003 Feb; 63(3):696-704. PubMed ID: 12566316
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of a novel enhancer for the human MCT-1 oncogene promoter.
Shi B; Levenson V; Gartenhaus RB
J Cell Biochem; 2003 Sep; 90(1):68-79. PubMed ID: 12938157
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte nuclear factor 3 is a major determinant of CYP2C6 promoter activity in hepatoma cells.
Shaw PM; Weiss MC; Adesnik M
Mol Pharmacol; 1994 Jul; 46(1):79-87. PubMed ID: 8058060
[TBL] [Abstract][Full Text] [Related]
38. Developmental regulation of osteocalcin expression in MC3T3-E1 osteoblasts: minimal role of the proximal E-box cis-acting promoter elements.
Quarles LD; Siddhanti SR; Medda S
J Cell Biochem; 1997 Apr; 65(1):11-24. PubMed ID: 9138076
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation of human adrenomedullin gene in vascular endothelial cells.
Ishimitsu T; Miyata A; Matsuoka H; Kangawa K
Biochem Biophys Res Commun; 1998 Feb; 243(2):463-70. PubMed ID: 9480831
[TBL] [Abstract][Full Text] [Related]
40. Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
Aoki K; Kato J; Shoemaker MT; Moss J
Gene; 2005 May; 351():83-95. PubMed ID: 15893437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
